Summit Global Investments - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 2 filers reported holding IRADIMED CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$257
-6.9%
5,7880.0%0.02%
-5.6%
Q2 2023$276
-6.4%
5,788
-22.8%
0.02%
-21.7%
Q1 2023$295
-99.9%
7,500
-31.8%
0.02%
-17.9%
Q3 2021$369,000
+25.1%
11,000
-20.3%
0.03%
-6.7%
Q3 2020$295,000
-56.3%
13,800
-52.6%
0.03%
-61.5%
Q2 2020$675,000
+15.4%
29,100
+6.2%
0.08%
-8.2%
Q1 2020$585,00027,4000.08%
Other shareholders
IRADIMED CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 771,311$34,223,00010.44%
RK Capital 300,800$13,346,4963.16%
Soleus Capital Management, L.P. 628,206$27,873,5002.57%
Ballast Asset Management, LP 25,088$1,113,1551.03%
Bridge City Capital, LLC 28,172$1,249,9920.63%
Ranger Investment Management 212,147$9,412,9620.62%
Bares Capital Management 277,000$12,290,4900.52%
Riverwater Partners LLC 11,636$516,2890.47%
Hillsdale Investment Management Inc. 90,010$3,993,7440.37%
SHAKER INVESTMENTS LLC/OH 12,919$573,2160.32%
View complete list of IRADIMED CORP shareholders